Delivery Order SPE2D021D0005-SPE2D325F8992

Award Date 4/1/25
Potential Completion Date 4/4/25
Potential Value $5.4K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $9,507 to Genentech USA, Inc. of South San Francisco, California. The order is for 4558322500 TNKASE 50 MG KITS to be delivered between August 31 and September 6, 2022. Genentech will provide the pharmaceutical products to the Defense Logistics Agency as the prime contractor. No subcontractors or set aside designations were indicated. The Defense Logistics Agency Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit biotechnology and pharmaceutical manufacturer. The $872,420.96 firm fixed-price contract is for the provision of various medical supplies and pharmaceuticals, including critical medications such as Tamiflu, Activase, TNKase, and Xofluza, as well as routine medications like clonazepam and diazepam tablets. The contract has an ultimate completion date of June 22,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc. for the pharmaceutical product Activase (alteplase). The $3,256.83 firm-fixed-price contract has an ultimate completion date of August 12, 2024. Genentech, a foreign-owned, for-profit manufacturer of pharmaceuticals and biologics, has provided a range of medical products to federal agencies including the Departments of Defense, Health and Human Services, Justice, and Veterans Affairs. Genentech holds...
This federal contract award, valued at $10,206.61, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of 4563527257 TNKASE 50 MG KITS, a pharmaceutical product. The contract does not have any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award from the Defense Logistics Agency (DLA) was issued to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,910.68 firm fixed-price delivery order covers the procurement of 4555771666 TNKASE 50 MG KITS. The contract has an ultimate completion date of December 22, 2021 and was awarded on December 21, 2021. This delivery order falls under a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop...
This is a $63,884.33 firm-fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of TNKASE 50 MG KITS medical supplies, with a period of performance through May 22, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) awarded a $7,985.32 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Tenecteplase Injection Kits. This delivery order was issued under DMS Pharmaceutical Group's existing $499,999,999 indefinite delivery contract (IDC) with the DLA, which supports the recurring pharmaceutical supply needs of military health facilities worldwide. The IDC, under the DLA's SPE2DB program, allows the agency...
The federal contract award is for the delivery of 4566119553 TNKASE 50 MG KITS to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $12,854.22 and an ultimate completion date of October 17, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing type. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is not associated with a set-aside designation,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TNKASE 50 MG KITS, a medical product, with a ceiling value of $9,875.17. The contract is a Firm Fixed Price Delivery Order and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of pharmaceutical products, specifically TNKASE 50 MG KITS, to the Defense Logistics Agency (DLA). The contract, valued at $13,745.76, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, on May 8, 2024 with a completion date of May 9, 2024. The contract is a delivery order with a firm fixed price pricing type. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to...
  • SPE2D021D0005
    Indefinite Delivery Contract
  • SPE2D021D0005-SPE2D325F8992
    Delivery Order

This contract award to Genentech USA, Inc., a foreign-owned, for-profit biotechnology and pharmaceutical manufacturer, is a delivery order valued at $5,369.85 for the supply of TNKASE 50 MG KITS. The award was made by the Defense Logistics Agency (DLA), a defense agency, under a contract with a period of performance ending on April 4, 2025. The contract is a firm fixed-price type without any set-aside designation, indicating open competition. Genentech is a significant supplier of critical medications and pharmaceuticals to various federal agencies, including the Department of Veterans Affairs and the Federal Bureau of Investigation, through established contract vehicles such as Federal Supply Schedules and Indefinite Delivery Contracts.

Generated 7/1/25, 11:13 AM